The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

por Reinisch, W, Chowers, Y, Danese, S, Dignass, A, Gomollón, F, Haagen Nielsen, O, Lakatos, P L, Lees, C W, Lindgren, S, Lukas, M, Mantzaris, G J, Michetti, P, Moum, B, Peyrin-Biroulet, L, Toruner, M, Woude, J, Weiss, G, Stoevelaar, H
Publicado 2013

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

por Goll, G. L., Jørgensen, K. K., Sexton, J., Olsen, I. C., Bolstad, N., Haavardsholm, E. A., Lundin, K. E. A., Tveit, K. S., Lorentzen, M., Berset, I. P., Fevang, B. T. S., Kalstad, S., Ryggen, K., Warren, D. J., Klaasen, R. A., Asak, Ø., Baigh, S., Blomgren, I. M., Brenna, Ø., Bruun, T. J., Dvergsnes, K., Frigstad, S. O., Hansen, I. M., Hatten, I. S. H., Huppertz‐Hauss, G., Henriksen, M., Hoie, S. S., Krogh, J., Midtgard, I. P., Mielnik, P., Moum, B., Noraberg, G., Poyan, A., Prestegård, U., Rashid, H. U., Strand, E. K., Skjetne, K., Seeberg, K. A., Torp, R., Ystrøm, C. M., Vold, C., Zettel, C. C., Waksvik, K., Gulbrandsen, B., Hagfors, J., Mørk, C., Jahnsen, J., Kvien, T. K.
Publicado 2019